Efficacy of PEGylated human IL-10 (AM0010) in combination with anti-PD-1 blockade in patients (pts) with metastatic renal cell carcinoma (mRCC): A phase 1b trial Meeting Abstract


Authors: Naing, A.; Infante, J.; Wong, D.; Korn, W. M.; Aljumaily, R.; Papadopoulos, K.; Autio, K.; Pant, S.; Bauer, T.; Drakaki, A.; Daver, N.; Hung, A.; van Vlasselaer, P.; Oft, M.; Tannir, N.
Abstract Title: Efficacy of PEGylated human IL-10 (AM0010) in combination with anti-PD-1 blockade in patients (pts) with metastatic renal cell carcinoma (mRCC): A phase 1b trial
Meeting Title: ESMO Immuno Oncology Congress 2017
Journal Title: Annals of Oncology
Volume: 28
Issue: Suppl. 11
Meeting Dates: 2017 Dec 7-10
Meeting Location: Geneva, Switzerland
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2017-12-01
Start Page: mdx712
Language: English
ACCESSION: WOS:000424778900095
PROVIDER: wos
DOI: 10.1093/annonc/mdx712
Notes: Meeting Abstract: 3O -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karen Anne Autio
    119 Autio